Paroxetine retards disease onset and progression in Huntingtin mutant mice

Authors:
  • ZGZhihong Guo
    Zhihong Guo
  • HJHaiyang Jiang
    Haiyang Jiang
  • BLBruce Ladenheim
    Bruce Ladenheim
  • XXXiangru Xu
    Xiangru Xu
  • JCJean Lud Cadet
    Jean Lud Cadet

Abstract
We report that administration of paroxetine, a widely prescribed antidepressant drug that acts by inhibiting reuptake of the neurotransmitter serotonin, suppresses the neurodegenerative process and increases the survival of huntingtin mutant mice, an animal model of Huntington's disease (HD). Paroxetine attenuated motor dysfunction and body weight loss and improved glucose metabolism in the HD mice. Paroxetine was beneficial when treatment was initiated before or after the onset of motor dysfunction, suggesting a potential for such antidepressant drugs in the treatment of presymptomatic and symptomatic HD patients.

This publication has 20 references indexed in Scilit: